# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3537745 | A | Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
2. | ALA3537746 | A | Drug metabolism assessed as recombinant CYP3A5 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
3. | ALA3537747 | A | Drug metabolism assessed as recombinant CYP2C8 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
4. | ALA3537748 | A | Drug metabolism assessed as recombinant CYP3A4 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
5. | ALA3537749 | A | Drug metabolism assessed as recombinant CYP3A7 (unknown origin)-mediated compound formation treated with AMG 853 at 10 uM after 30 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
6. | ALA3538096 | A | Drug metabolism in human liver microsomes treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | assay format | Scientific Literature | |
7. | ALA3538274 | A | Drug metabolism in human liver microsomes assessed as CYP3A5*1/*1-mediated compound formation treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | assay format | Scientific Literature | |
8. | ALA3538275 | A | Drug metabolism in human liver microsomes assessed as CYP3A5*3/*3-mediated compound formation treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | assay format | Scientific Literature | |
9. | ALA3538276 | A | Drug metabolism in human lung microsomes treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | assay format | Scientific Literature | |
10. | ALA3538277 | A | Drug metabolism assessed as recombinant CYP2C8 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
11. | ALA3538278 | A | Drug metabolism assessed as recombinant CYP2J2 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
12. | ALA3538279 | A | Drug metabolism assessed as recombinant CYP3A4 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
13. | ALA3538280 | A | Drug metabolism assessed as recombinant CYP3A5 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
14. | ALA3538281 | A | Drug metabolism assessed as recombinant CYP3A7 (unknown origin)-mediated compound formation measured per nmol protein treated with AMG 853 after 15 mins by LC-MS/MS analysis | Homo sapiens | 2 | ALA3526017 | single protein format | Scientific Literature | |
15. | ALA3534692 | A | Inhibition of recombinant CYP2C8 (unknown origin) treated with AMG 853 | Homo sapiens | 1 | ALA3526017 | single protein format | Scientific Literature | |
16. | ALA3534693 | A | Inhibition of recombinant CYP2J2 (unknown origin) treated with AMG 853 | Homo sapiens | 1 | ALA3526017 | single protein format | Scientific Literature |